0001437749-15-016755.txt : 20150901
0001437749-15-016755.hdr.sgml : 20150901
20150901192342
ACCESSION NUMBER: 0001437749-15-016755
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150831
FILED AS OF DATE: 20150901
DATE AS OF CHANGE: 20150901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPAX LABORATORIES INC
CENTRAL INDEX KEY: 0001003642
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650403311
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
BUSINESS PHONE: 510-240-6000
MAIL ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENET LESLIE Z
CENTRAL INDEX KEY: 0001245186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34263
FILM NUMBER: 151088337
MAIL ADDRESS:
STREET 1: UCSF BIOPHARMACEUTICAL SCIENCES
STREET 2: 533 PARNASSUS AVENUE, ROOM U68
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94143
4
1
rdgdoc.xml
FORM 4
X0306
4
2015-08-31
0001003642
IMPAX LABORATORIES INC
IPXL
0001245186
BENET LESLIE Z
C/O IMPAX LABORATORIES, INC.
30831 HUNTWOOD AVENUE
HAYWARD
CA
94544
1
Common Stock
2015-08-31
4
M
0
3000
18.09
A
12200
D
Common Stock
2015-08-31
4
S
0
3000
40.92
D
9200
D
Common Stock
2015-08-31
4
M
0
3000
20.47
A
12200
D
Common Stock
2015-08-31
4
S
0
3000
40.92
D
9200
D
Common Stock
2015-08-31
4
M
0
3000
25.18
A
12200
D
Common Stock
2015-08-31
4
S
0
3000
40.92
D
9200
D
Common Stock
2015-08-31
4
M
0
3000
23.60
A
12200
D
Common Stock
2015-08-31
4
S
0
3000
40.92
D
9200
D
Common Stock
2015-08-31
4
M
0
2750
29.03
A
11950
D
Common Stock
2015-08-31
4
S
0
2750
40.92
D
9200
D
Common Stock
2015-08-31
4
M
0
2750
27.80
A
11950
D
Common Stock
2015-08-31
4
S
0
2750
40.92
D
9200
D
Common Stock
2015-08-31
4
M
0
2500
6.55
A
11700
D
Common Stock
2015-08-31
4
S
0
2500
40.92
D
9200
D
Common Stock
600
I
By the Benet Family Trust
Stock Option (Right to Buy)
18.09
2015-08-31
4
M
0
3000
0
D
2018-06-21
Common Stock
3000
0
D
Stock Option (Right to Buy)
20.47
2015-08-31
4
M
0
3000
0
D
2018-10-25
Common Stock
3000
0
D
Stock Option (Right to Buy)
25.18
2015-08-31
4
M
0
3000
0
D
2019-01-03
Common Stock
3000
0
D
Stock Option (Right to Buy)
23.60
2015-08-31
4
M
0
3000
0
D
2019-04-04
Common Stock
3000
0
D
Stock Option (Right to Buy)
29.03
2015-08-31
4
M
0
2750
0
D
2019-07-11
Common Stock
2750
0
D
Stock Option (Right to Buy)
27.80
2015-08-31
4
M
0
2750
0
D
2019-10-24
Common Stock
2750
0
D
Stock Option (Right to Buy)
6.55
2015-08-31
4
M
0
2500
0
D
2019-05-20
Common Stock
2500
53500
D
The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $40.37 to $41.87 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
100% of the shares subject to the option are fully vested and exercisable.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Mark A. Schlossberg, by Power of Attorney
2015-09-01